Support program for individuals with early-stage memory loss living alone

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

EPICLA+ is a program designed to assist individuals aged 60 and older with early-stage memory loss or dementia who live alone. The program offers education and skill-training sessions via Zoom to help participants manage challenges, reduce stress, and enhance their overall well-being. Participants will engage in group sessions, individualized support, and interviews to provide feedback and improve the program. The study aims to create a supportive community for those facing early-stage cognitive decline.

Why it matters

Who can join: the full rules

Early-stage inclusion criteria

1. Must be at least 60 years of age
2. Must be able to participate in English or Spanish
3. Must be a US resident
4. Must be able to provide consent verbally and in writing (electronically or via mail)
5. Must exhibit at least 2 of 8 changes caused by thinking and memory problems on the AD8 (a reliable and valid 8-item dementia screening tool).
6. The Early-stage individual must have a diagnosis of early-stage ADRD or have a Mini-Mental State Exam (MMSE) score:

   1. between 20-26 for those who have completed high school, or
   2. between 17-26\*, for those who have not completed high school, or
   3. 27 or higher with a confirmed diagnosis of early-stage dementia or MCI.
7. Able to participate in EPIC-LA workshops via zoom

   Exclusion Criteria:
8. Inability to participate via telephone or online video conferencing service.
9. The participant expresses feelings of not wanting to participate
10. The participant do not have enough time to attend the training,
11. The participant demonstrates lack of skills with using a computer that precludes participation
12. The participant does not have a stable internet connection to connect to the video platform
13. The participant has difficulty hearing or a visual impairment that precludes participation.

Where it's running

• Arizona State University
  Phoenix, Arizona, United States Recruiting

Study contacts

• Principal investigator: Dr. Gomez-Morales — Asu
• Study coordinator: Dr. Gomez-Morales, PhD
• Email: agomezm1@asu.edu
• Phone: 602-543-6672

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Improving symptoms of mild cognitive impairment and early dementia with brain stimulation

  This study is testing a new brain stimulation treatment combined with mental exercises to see if it can help people with mild cognitive impairment and early dementia feel better.

  Recruiting University of Campania Luigi Vanvitelli · Caserta, Italy · NCT06668610

• China HEAD: a large community study on healthy aging and dementia

  This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.

  Recruiting at 30 sites Fudan University · Beijing and 29 other locations · NCT07912710

• Aging Brain Health Initiative in Fujian

  This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.

  Recruiting at 4 sites Fujian Medical University Union Hospital · Fushun, Fujian and 3 other locations · NCT07891429

• Blood biomarker cohort for memory disorders in older adults

  This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.

  Recruiting Yonsei University · Seoul, Seodamun-gu · NCT07880275

• Photobiomodulation therapy for mild cognitive impairment and mild Alzheimer's disease

  This trial tests whether daily transcranial near-infrared light therapy, versus a sham device, can improve cognitive function in adults with mild cognitive impairment or mild Alzheimer's disease.

  Recruiting Beijing Tiantan Hospital · Beijing · NCT07835399

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.